BLOCKING 17B-HYDROXYSTEROID DEHYDROGENASE TYPE 1 IN ENDOMETRIAL CANCER: A POTENTIAL NOVEL ENDOCRINE THERAPEUTIC APPROACH

被引：0
|
作者：
Cornel, K. M. C. [1 ,2 ]
Konings, G. [2 ,3 ]
Xanthoulea, S. [2 ,3 ]
Delvoux, B. [3 ]
Skowron, M. A. [4 ]
Kooreman, L. [1 ,5 ]
Koskimies, P. [6 ]
Krakstad, C. [7 ,8 ]
Salvesen, H. B. [7 ,8 ]
van Kuijk, K. [1 ,2 ]
Schrooders, Y. J. [1 ,2 ]
Vooijs, M. [1 ,9 ]
Groot, A. J. [1 ,9 ]
Bongers, M. Y. [1 ,2 ]
Kruitwagen, R. R. [1 ,2 ]
Romano, A. [1 ,2 ]
机构：
[1] Maastricht Univ, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands
[2] Maastricht Univ, Med Ctr, Gynaecol & Obstet, Maastricht, Netherlands
[3] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands
[4] Heinrich Heine Univ Dusseldorf, Urol, Dusseldorf, Germany
[5] Maastricht Univ, Med Ctr, Pathol, Maastricht, Netherlands
[6] Forendo Pharma Ltd, Turku, Finland
[7] Haukeland Hosp, Gynaecol & Obstet, Bergen, Norway
[8] Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers, Bergen, Norway
[9] Maastricht Univ, Dept Radiotherapy MAASTRO, Maastricht, Netherlands
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2019年 / 29卷
关键词：
D O I：
10.1136/ijgc-2019-ESGO.560
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP502
引用
收藏
页码：A312 / A313
页数：2
相关论文
共 50 条
  • [31] Inhibition of 11B-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target
    Wamil, Malgorzata
    Seckl, Jonathan R.
    DRUG DISCOVERY TODAY, 2007, 12 (13-14) : 504 - 520
  • [32] 17β-Hydroxysteroid dehydrogenase type 1 as predictor of tamoxifen response in premenopausal breast cancer
    Kallstrom, Ann-Christine
    Salme, Rebecka
    Ryden, Lisa
    Nordenskjold, Bo
    Jonsson, Per-Ebbe
    Stal, Olle
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (05) : 892 - 900
  • [33] 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibition: A Potential Treatment Option for Non-Small Cell Lung Cancer
    Gargano, Emanuele M.
    Mohamed, Abdelrahman
    Abdelsamie, Ahmed S.
    Mangiatordi, Giuseppe F.
    Drzewiecka, Hanna
    Jagodzinski, Pawel P.
    Mazzini, Arcangela
    van Koppen, Chris J.
    Laschke, Matthias W.
    Nicolotti, Orazio
    Carotti, Angelo
    Marchais-Oberwinkler, Sandrine
    Hartmann, Rolf W.
    Frotscher, Martin
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (12): : 1920 - 1924
  • [34] Acarbose a promising inhibitor of 17®-hydroxysteroid dehydrogenase type 1 as a potential candidate for anticancer therapy
    Sebbar, E.
    El Moujtahide, D.
    Dalli, M.
    Choukri, M.
    CLINICA CHIMICA ACTA, 2024, 558
  • [35] Novel Hydroxysteroid (17β) Dehydrogenase 1 Inhibitors Reverse Estrogen-Induced Endometrial Hyperplasia in Transgenic Mice
    Saloniemi, Taija
    Jarvensivu, Paivi
    Koskimies, Pasi
    Jokela, Heli
    Lamminen, Tarja
    Ghaem-Maghami, Sadaf
    Dina, Roberto
    Damdimopoulou, Pauliina
    Makela, Sari
    Perheentupa, Antti
    Kujari, Harry
    Brosens, Jan
    Poutanen, Matti
    AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (03): : 1443 - 1451
  • [36] Modification of estrone at the 6, 16, and 17 positions:: Novel potent inhibitors of 17β-hydroxysteroid dehydrogenase type 1
    Allan, GM
    Lawrence, HR
    Cornet, J
    Bubert, C
    Fischer, DS
    Vicker, N
    Smith, A
    Tutill, HJ
    Purohit, A
    Day, JM
    Mahon, MF
    Reed, MJ
    Potter, BVL
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (04) : 1325 - 1345
  • [37] DETERMINANTS OF INTRATUMOURAL OESTRADIOL (E2) CONCENTRATIONS IN POSTMENOPAUSAL BREAST CANCER: ROLES FOR OESTROGEN RECEPTOR (ER) AND 17B-HYDROXYSTEROID DEHYDROGENASE 7 (HSD17B7)
    Haynes, B.
    Straume, A.
    Geisler, J.
    Ahern, R.
    Lonning, P.
    Dowsett, M.
    ANNALS OF ONCOLOGY, 2009, 20 : 51 - 52
  • [38] 17β-hydroxysteroid dehydrogenase type 1 expression is down-regulated in primary colorectal cancer
    Rawluszko, A. A.
    Horbacka, K.
    Krokowicz, P.
    Jagodzinski, P. P.
    FEBS JOURNAL, 2010, 277 : 295 - 295
  • [39] In silico analysis of potential inhibitors for breast cancer targeting 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) catalyses
    Islam, Md. Rezaul
    Tayyeb, Jehad Zuhair
    Paul, Hridoy Kumar
    Islam, Mirza Nafeul
    Oduselu, Gbolahan Oladipupo
    Bayil, Imren
    Abdellattif, Magda H.
    Al-Ahmary, Khairia Mohammed
    Al-Mhyawi, Saedah R.
    Zaki, Magdi E. A.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (15)
  • [40] E-ring modified steroids as novel potent inhibitors of 17β-hydroxysteroid dehydrogenase type 1
    Fischer, DS
    Allan, GM
    Bubert, C
    Vicker, N
    Smith, A
    Tutill, HJ
    Purohit, A
    Wood, L
    Packham, G
    Mahon, MF
    Reed, MJ
    Potter, BVL
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (18) : 5749 - 5770
12345